Loading...
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation
OBJECTIVE: To assess the cost-effectiveness of dabigatran etexilate, a new oral anticoagulant, versus warfarin and other alternatives for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation (AF). METHODS: A Markov model estimated the cost-effectiveness of dabigatra...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Group
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3308473/ https://ncbi.nlm.nih.gov/pubmed/22422743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2011-300646 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|